Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
39,383,430
-
Share change
-
+11,574,261
-
Total reported value
-
$658,088,801
-
Put/Call ratio
-
29%
-
Price per share
-
$16.72
-
Number of holders
-
103
-
Value change
-
+$203,357,999
-
Number of buys
-
68
-
Number of sells
-
29
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2021
As of 31 Dec 2021,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,383,430 shares.
The largest 10 holders included
Bellevue Group AG, Avidity Partners Management LP, BlackRock Inc., FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Logos Global Management LP, MORGAN STANLEY, and SUVRETTA CAPITAL MANAGEMENT, LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.